UroGen Pharma Stock Forward View - Relative Strength Index
| URGN Stock | USD 20.00 0.30 1.52% |
UroGen Stock outlook is based on your current time horizon.
As of today, the value of RSI of UroGen Pharma's share price is approaching 47. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling UroGen Pharma, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
Using UroGen Pharma hype-based prediction, you can estimate the value of UroGen Pharma from the perspective of UroGen Pharma response to recently generated media hype and the effects of current headlines on its competitors.
UroGen Pharma after-hype prediction price | USD 20.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of UroGen Pharma to cross-verify your projections. To learn how to invest in UroGen Stock, please use our How to Invest in UroGen Pharma guide.UroGen Pharma Additional Predictive Modules
Most predictive techniques to examine UroGen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for UroGen using various technical indicators. When you analyze UroGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 47.73 | 47.73 |
| Check UroGen Pharma Volatility | Backtest UroGen Pharma | Information Ratio |
UroGen Pharma Trading Date Momentum
| On February 03 2026 UroGen Pharma was traded for 20.00 at the closing time. The top price for the day was 20.16 and the lowest listed price was 19.13 . The trading volume for the day was 706.7 K. The trading history from February 3, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 2.45% . |
| Compare UroGen Pharma to competition |
Other Forecasting Options for UroGen Pharma
For every potential investor in UroGen, whether a beginner or expert, UroGen Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. UroGen Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in UroGen. Basic forecasting techniques help filter out the noise by identifying UroGen Pharma's price trends.UroGen Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with UroGen Pharma stock to make a market-neutral strategy. Peer analysis of UroGen Pharma could also be used in its relative valuation, which is a method of valuing UroGen Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
UroGen Pharma Market Strength Events
Market strength indicators help investors to evaluate how UroGen Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading UroGen Pharma shares will generate the highest return on investment. By undertsting and applying UroGen Pharma stock market strength indicators, traders can identify UroGen Pharma entry and exit signals to maximize returns.
UroGen Pharma Risk Indicators
The analysis of UroGen Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in UroGen Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting urogen stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.33 | |||
| Semi Deviation | 4.15 | |||
| Standard Deviation | 4.88 | |||
| Variance | 23.77 | |||
| Downside Variance | 18.48 | |||
| Semi Variance | 17.18 | |||
| Expected Short fall | (3.94) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for UroGen Pharma
The number of cover stories for UroGen Pharma depends on current market conditions and UroGen Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that UroGen Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about UroGen Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
UroGen Pharma Short Properties
UroGen Pharma's future price predictability will typically decrease when UroGen Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of UroGen Pharma often depends not only on the future outlook of the potential UroGen Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. UroGen Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42.9 M | |
| Cash And Short Term Investments | 236.7 M |
Check out Historical Fundamental Analysis of UroGen Pharma to cross-verify your projections. To learn how to invest in UroGen Stock, please use our How to Invest in UroGen Pharma guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Will Stock sector continue expanding? Could UroGen diversify its offerings? Factors like these will boost the valuation of UroGen Pharma. If investors know UroGen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every UroGen Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate UroGen Pharma using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating UroGen Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause UroGen Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between UroGen Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if UroGen Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, UroGen Pharma's market price signifies the transaction level at which participants voluntarily complete trades.